Le Lézard
Classified in: Environment, Health, Science and technology, Business
Subjects: TDS, RCY, SRI, FVT

Calyxt to Present at the 2021 Canaccord Genuity AgriFood Tech Innovation Virtual Forum


ROSEVILLE, Minn., Nov. 23, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced that management will present at the 2021 Canaccord Genuity AgriFood Tech Innovation Virtual Forum.

2021 Canaccord Genuity AgriFood Tech Innovation Virtual Forum
Date: Thursday, December 2, 2021
Time: 11:00 a.m. ET (8:00 a.m. PT)
Webcast: https://wsw.com/webcast/canaccord62/clxt/2475458

The presentation will be available for viewing and replay on the Investors section of Calyxt's website at www.calyxt.com.

Management is also available for meetings during the conference, please reach out to the event organizers or [email protected] to schedule.

About Calyxt
Calyxt (Nasdaq: CLXT) is a plant-based synthetic biotechnology company. The Company leverages its proprietary PlantSpringtm technology platform to engineer innovative materials and products for its customers to help them meet their sustainability goals. Calyxt's diversified offerings are primarily delivered through its proprietary BioFactorytm production system. For more information, visit www.calyxt.com

Contact:




Calyxt Media Contact:

Calyxt Investor Relations Contact:

 David Rosen

 Sherri Spear

 Argot Partners

 Argot Partners

 (212) 600-1902

 (212) 600-1902

 [email protected]

 [email protected]

 

SOURCE Calyxt, Inc.


These press releases may also interest you

at 04:10
Amgen  today announced three new data sets from its thoracic oncology portfolio that will be presented at the International Association for the Study of Lung Cancer (IASLC) 2022 World...

at 04:10
The protocol used to screen and detect lung cancer in the NELSON Trial is more sensitive than the protocol used in the National Lung Cancer Screening Trial,...

at 04:10
Today, representatives from the Diagnostics Working Group of the IASLC Early Detection and...

at 03:20
BiomX Inc. ("BiomX" or the "Company"), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio...

at 03:00
Viewpoint, an informational television program hosted by award-winning actor Dennis Quaid, will highlight men's health in a soon-to-be-created episode. Industry professionals will go into depth in the program discussing different aspects of men's...

6 aoû 2022
Epigenic Therapeutics Co., Ltd., a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for wide variety of diseases, today announced it has secured $20 million in...



News published on 23 november 2021 at 07:00 and distributed by: